Pharmacological treatment and current controversies in COPD [version 1; peer review: 3 approved]
Bronchodilators, corticosteroids, and antibiotics are still key elements for treating chronic obstructive pulmonary disease in the 2019 Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations and this is due in part to our current inability to discover new drugs capable of deci...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2019-08-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/8-1533/v1 |